Navigation Links
Indivumed Appoints Annette Kassen as Vice President Clinical Research
Date:4/9/2008

ivumed

Indivumed is a privately held biotech company focused on the generation, characterization and analysis of highly standardized biological samples from human cancer. Founded in 2002 and headquartered in Hamburg, Germany, with a subsidiary in Kensington, Maryland, USA, Indivumed has cooperation agreements with all major oncological hospitals in the Hamburg metropolitan area as well as with Georgetown University Hospital, Washington, D.C. Indivumed's current tumor biobank of over 8,000 patient-cases, collected with a mean cold ischemia time of less than eight minutes, serves as a resource for Indivumed's internal cancer research in biomarkers and primary cell drug screening as well as for the use of pharmaceutical and biopharma partners through tumor biobank access and a variety of services, such as e.g. IHC and drug profiling.


'/>"/>
SOURCE Indivumed
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development
2. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
3. Codexis Appoints Singapore Laboratories Managing Director
4. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
5. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
8. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
9. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
10. NeurogesX Appoints New Director to the Board
11. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... in the Nation ,, PHILADELPHIA, Dec. 16 ... has been granted Magnet(R) recognition by the American ... is one of the highest levels of recognition ... places Hahnemann among the five percent of hospitals ... distinction. ,, At 9:00 am on Monday, Hahnemann ...
(Date:12/16/2009)... Resources, one of the world,s leading research and ... that, according to responses from surveyed dermatologists, Centocor ... inhibitors) will capture 22 percent of the biologics ... moderate to severe psoriasis. Among these two agents, ... times as much patient share as briakinumab. ...
(Date:12/16/2009)... supplement? InVitria has what scientists have been asking for! Zap-CHO ... the growth and productivity of CHO cells. Developed for scientists ... free, well defined and consistent recombinant CHO supplement. , ... ... 2009 -- Scientists working with CHO cells can now access ...
(Date:12/15/2009)... MARINO, Calif., Dec. 15 Epeius Biotechnologies ... targeted genetic medicine, gained international validation of the ... Rexin-G , when scientists around the world rediscovered ... a major locus of cancer pathogenesis and disease ... therapies. Recently, scientists at the NIH National Cancer ...
Breaking Biology Technology:Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... PLSG Invests More Than $.5 million in Three ... Life Sciences,Greenhouse (PLSG), the private/public partnership putting the ... growth, announced that the PLSG has,invested a total ... and Blue Belt Technologies. "We are very ...
... DALLAS, Sept. 11 ACCESS PHARMACEUTICALS, INC.,(OTC ... business columnist,Gene Marcial of BusinessWeek, highlighted Access ... 17, 2007. The article is also available,on ... Street, column. The article focused upon ...
... role on the nation,s obesity crisis by addressing ... genetics associated with hunger and excess weight., SAN ... wellness company, announced the launch of GenoTrim, a DNA-based,nutritional ... through both standard weight reduction strategies and numerous,"gimmicks" have ...
Other Biology Technology:The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio 2The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio 3The Pittsburgh Life Sciences Greenhouse Adds to Its Investment Portfolio 4Access Highlighted in Recent BusinessWeek Article 2Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management 2Salugen Announces the U.S. Launch of GenoTrim - a DNA Customized Nutritional Solution for Weight Management 3
(Date:12/16/2009)... Knowledge and Innovation Community (Climate-KIC)" is a major initiative ... program brings together the expertise of world class partners ... Europe,s innovation capacity to meet the climate change challenge ... a new low-carbon society. In responding to this challenge, ... produce, distribute, and consume goods, and to how we ...
(Date:12/16/2009)... network of interactions. Today,s techniques, however, can only ... the cells. Since molecular concentrations are much higher ... that the kinetics of molecular reactions in living ... the cellular reaction speed to be higher," confirms ... optical approach showed that depending on the ...
(Date:12/16/2009)... Maryland School of Medicine researcher will lead the coordinating ... scientists in the field of stem cell research. Michael ... was chosen by the National Heart, Lung and Blood ... of national experts, which will be called the NHLBI ... funded by a $30 million grant over seven years. ...
Breaking Biology News(10 mins):Innovation boost to tackle climate change 2Innovation boost to tackle climate change 3Looking for the heartbeat of cellular networks 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday October 28 at 5 3A00 p m ET 14295 1BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday October 28 at 5 3A00 p m ET 14295 2Breast Cancer Death Rates Continue to Drop 2 25 Annually 58525 1Breast Cancer Death Rates Continue to Drop 2 25 Annually 58525 2Breast Cancer Death Rates Continue to Drop 2 25 Annually 58525 3A new chemical method for distinguishing between farmed and wild salmon 10178 1A new chemical method for distinguishing between farmed and wild salmon 10178 2
... CHAMPAIGN, Ill. Scientists at the University of ... microplate-based optical biosensors capable of detecting protein-DNA interactions. ... biosensors are suitable for the rapid identification of ... "Protein-DNA interactions are essential for fundamental cellular processes ...
... Ammonia emissions from seabirds have been shown to ... coastal ecosystems, contributing to nutrient enrichment (eutrophication) and ... from domesticated animals such as poultry and pigs, ... to the atmosphere in remote regions. ...
... disorder called tuberous sclerosis complex (TSC) is yielding insight ... abnormalities in neurons, or brain cells. Researchers in the ... by Mustafa Sahin, MD, PhD, and Xi He, PhD, ... restored. , If this could be done safely ...
Other Biology News:Photonic crystal biosensors detect protein-DNA interactions 2Rare genetic disorder gives clues to autism, epilepsy, mental retardation 2